The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision.
COVID-19 and psoriasis: Should we fear for patients treated with biologics? / Amerio P.; Prignano F.; Giuliani F.; Gualdi G.. - In: DERMATOLOGIC THERAPY. - ISSN 1396-0296. - ELETTRONICO. - 33:(2020), pp. 1-1. [10.1111/dth.13434]
COVID-19 and psoriasis: Should we fear for patients treated with biologics?
Prignano F.;
2020
Abstract
The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dermatologic Therapy - 2020 - Amerio - COVID‐19 and psoriasis Should we fear for patients treated with biologics.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
576.71 kB
Formato
Adobe PDF
|
576.71 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
